● TIER 3 — Information onlyGRADE B (topical)Skin / collagen
GHK-Cu
Copper tripeptide. Research verification: Yes (TGA pending). 1 human study record(s) in the FitClinicMD studies database.
GOALS · Skin · Recovery / injury
FDA status
Not approved as drug; topical cosmetic use legal.
Compounding (503A/503B)
Non-injectable GHK-Cu: 503A Category 1 (re-added after May 5 2026 clarification); injectable: nominated-but-withdrawn; PCAC review planned before end Feb 2027
DEA
Not controlled.
WADA (sport)
Not listed on 2026 Prohibited List (no matching section found)
Mechanism
Copper-binding tripeptide; collagen synthesis in vitro.
Human evidence · 1
Review of GHK anti-aging data (2020). The potential of GHK as an anti-aging peptide.
Reference only. This page summarizes publicly available regulatory and research information about GHK-Cu. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.